文献速递妇科

醋酸乌利司他治疗下子宫肌瘤体积缩小的预测因素:一项前瞻性磁共振成像研究

Predictors of uterine fibroid volume reduction under ulipristal acetate: a prospective MRI study.
PubMed 文献 · Reprod Biomed Online · 2019-07-17

这项单中心观察性前瞻性队列研究纳入53名有症状的子宫肌瘤女性,每日口服5毫克醋酸乌利司他治疗3个月后手术,治疗前后行磁共振成像测量三个最大肌瘤体积。结果显示肌瘤初始数目和初始体积与治疗反应独立相关,黏膜下肌瘤的反应率高于肌壁间肌瘤。

要点

  • 肌瘤初始数目与治疗反应独立相关(校正OR 0.645,95%CI 0.461-0.903,P=0.0115)。
  • 肌瘤初始体积与治疗反应独立相关(校正OR 1.447,95%CI 1.063-1.970,P=0.0195),呈对数线性关系。
  • 黏膜下肌瘤反应率高于肌壁间肌瘤(21/25[84.0%] vs 15/28[53.6%],P=0.0490)。

核心结论

  • 肌瘤的位置、初始体积和数目可能有助于预测单次3个月每日5毫克醋酸乌利司他治疗术前缩小肌瘤体积的结局。

研究设计与样本

  • 单中心观察性前瞻性队列研究,纳入53名有症状的子宫肌瘤女性,每日口服5毫克醋酸乌利司他治疗3个月后愿意接受手术,治疗前后行磁共振成像测量三个最大肌瘤体积。

主要发现

  • 共测量116个肌瘤。
  • 肌瘤初始数目与治疗反应独立相关(校正OR 0.645,95%CI 0.461-0.903,P=0.0115)。
  • 肌瘤初始体积与治疗反应独立相关(校正OR 1.447,95%CI 1.063-1.970,P=0.0195),呈对数线性关系。
  • 黏膜下肌瘤的反应率高于肌壁间肌瘤(21/25[84.0%] vs 15/28[53.6%];P=0.0490;校正OR 4.478,95%CI 1.007-19.918)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Can patient and/or uterine fibroid characteristics predict the volume reduction of fibroids under ulipristal acetate (UPA) treatment? DESIGN: This was a monocentric observational prospective cohort study of women with symptomatic fibroids who were willing to undergo surgery after a 3-month treatment of daily 5 mg doses of UPA. Patients underwent magnetic resonance imaging before and after treatment, and the volumes of the three largest fibroids were assessed. The reduction in volume was assessed qualitatively: fibroids decreasing in volume were considered to be 'responsive' to treatment, and fibroids that were stable or increased in volume were considered to be 'non-responsive'. Comparisons were made of patient (age and body mass index) and fibroid (initial volume, number and location) characteristics between fibroids that were responsive and non-responsive to UPA treatment. RESULTS: Fifty-three women were included in the final analysis and 116 fibroids were measured. The initial number and initial volume of the fibroids were statistically associated with the response to UPA treatment (adjusted odds ratio [OR] 0.645, 95% confidence interval [CI] 0.461-0.903, P = 0.0115 for number of fibroids, and adjusted OR 1.447, 95% CI 1.063-1.970, P = 0.0195 for initial volume, with a log-linear relationship). Submucosal fibroids had a higher response rate to treatment (i.e. a decrease in volume) than intramural fibroids (21/25 [84.0%] versus 15/28 [53.6%]; P = 0.0490; adjusted OR 4.478, 95% CI 1.007-19.918). CONCLUSIONS: The location, initial volume and number of fibroids may allow prediction of the outcome of a single 3-month treatment course of daily 5 mg doses of UPA in terms of reduction in volume before surgery.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Netter A, Pauly V, Siles P, et al. Predictors of uterine fibroid volume reduction under ulipristal acetate: a prospective MRI study. Reprod Biomed Online. 2019. PMID: 31594689. doi:10.1016/j.rbmo.2019.07.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。